Lung - Cancer

Podcast

The Beat With Joel Dunning Ep. 176: The ELANA System in CABG

October 1, 2026 | Joel DunningGold ContributorSilver Commentor…

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Bart P. van Putte, a cardiothoracic surgeon at the St. Antonius Hospital in Nieuwegein, Netherlands, and the Amsterdam University Medical Center about the excimer...

JANS Article

Pope Leo XIV Undergoes Successful Lung Surgery

October 15, 2026 | Joel DunningGold ContributorSilver Commentor

This article summarizes the surgical treatment of Pope Leo XIV, who was recently diagnosed with lung adenocarcinoma. Surgeons performed a uniportal video-assisted thoracoscopic surgery (VATS) lobectomy. The surgery team reported...

Video

How to Perform a Left Robotic Pneumonectomy

October 5, 2026 | Sonia Aguir…

This video presents the authors’ standardized technique for multiportal robotic-assisted left pneumonectomy after neoadjuvant chemoimmunotherapy, using a five-step hilar dissection based on the principles of the French lobectomy approach. In...

Podcast

The Beat With Joel Dunning Ep. 176: The ELANA System in CABG

October 1, 2026 | Joel DunningGold ContributorSilver Commentor…

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Bart P. van Putte, a cardiothoracic surgeon at the St. Antonius Hospital in Nieuwegein, Netherlands, and the Amsterdam University...

JANS Article

Contemporary Chest Drain Practice After Pulmonary Resection

October 1, 2026 | Akshay PatelSilver Contributor

This prospective European Society of Thoracic Surgeons (ESTS) Drainology Collaborative registry study examined chest-drain practice after pulmonary resection in 3,348 patients across 21 international centers, 88 percent of whom underwent...

JANS Article

Touching (Proximity) as a Companion Diagnostic Test

June 5, 2025 | Akshay PatelSilver Contributor

This article discusses a promising diagnostic approach aimed at improving patient selection for immune checkpoint inhibitor (ICI) therapies, particularly in non-small cell lung cancer (NSCLC). The current reliance on PD-L1...

JANS Article

Advancing the Needle on the Management of Resectable EGFR-Positive NSCLC: Is Neoadjuvant Osimertinib the Answer?

June 5, 2025 | Akshay PatelSilver Contributor

This article reviews recent efforts to evaluate the use of osimertinib, a third-generation EGFR tyrosine kinase inhibitor (TKI), in the neoadjuvant setting for patients with resectable EGFR-mutant non-small cell lung...

JANS Article

Optimizing Surgical Precision: A Comparative Study of Three-Port vs. Four-Port Robotic-Assisted Lobectomy for NSCLC

May 7, 2025 | Jade QuSilver Contributor

This retrospective analysis compared three-port and four-port robotic-assisted thoracoscopic surgery (RATS) lobectomy for non-small cell lung cancer (NSCLC)(n=121, 2020–2021). Demographics, tumor characteristics, complications, and lymph node yields were similar between...

JANS Article

Extended Sleeve Lobectomy After Neoadjuvant Immunochemotherapy for Centrally Located Non-Small Cell Lung Cancer

May 1, 2025 | Jade QuSilver Contributor

Extended sleeve lobectomy (ESL) is considered a lung-sparing alternative to pneumonectomy (PN) for centrally located non-small cell lung cancer (NSCLC) when standard sleeve lobectomy (SSL) is not feasible. This retrospective...

JANS Article

Neoadjuvant Concurrent Chemo-Immuno-Radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage III N2 NSCLC: Primary Results From the SQUAT Trial (WJOG 12119L)

May 1, 2025 | Jade QuSilver Contributor

The recent CheckMate 816 trial indicated that neoadjuvant chemo-immunotherapy provided limited local control in stage II–III resectable non-small cell lung cancer (NSCLC). This trial evaluated the hypothesis that incorporating radiotherapy...

JANS Article

Estimated Worldwide Variation and Trends in Incidence of Lung Cancer by Histological Subtype in 2022 and Over Time: A Population-Based Study

April 17, 2025 | Akshay PatelSilver Contributor

This article presents a comprehensive epidemiological analysis of lung cancer, focusing on subtype-specific patterns worldwide. Using data from GLOBOCAN 2022 and other international cancer registries, the study estimated more than...

JANS Article

Tumour Spread Through Air Spaces Is a Determiner for Treatment of Clinical Stage I Non-Small Cell Lung Cancer: Thoracoscopic Segmentectomy vs Lobectomy

March 13, 2025 | Akshay PatelSilver Contributor

This study investigates the impact of tumor spread through air spaces (STAS) on surgical outcomes for early-stage non-small cell lung cancer (NSCLC). In a retrospective analysis of 785 patients, 19.2...

JANS Article

Lung Cancer Screening and USPSTF Recommendations

March 6, 2025 | Erica CurcioGold Contributor

Lung cancer remains the leading cause of cancer-related deaths, and low-dose computed tomography screening can reduce mortality for high-risk individuals. In 2021, the US Preventive Services Task Force (USPSTF) expanded...

LOAD MORE
ADVERTISE ON CTSNET